Clinical trial
The Leiden CONCERT Study 2.0 Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Non-Randomized Trial With Historical Control Group
NCT02005822 is registered in ClinicalTrials.gov with Dr. Ann C.T.M. Vossen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Leiden CONCERT Study 2.0 Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Non-Randomized Trial With Historical Control Group
- Lead sponsor
- Dr. Ann C.T.M. Vossen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 22, 2013
- Completion date
- May 17, 2018
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital cytomegalovirus infection, sensorineural hearing loss